Phase 3 results showed efficacy in primary biliary cholangitis involving Alp and Gilead Sciences.
1 report, 1 independent
Updated Jun 17
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Phase 3 results showed efficacy in primary biliary cholangitis involving Alp and Gilead Sciences.